Rotigotine Transdermal Patch Improves Swallowing in Dysphagic Patients with Parkinson’s Disease

Dysphagia

Volumn 30, Issue 4, 2015, Pages 452-456

  Hirano, Makito ^a   Isono, Chiharu ^a   Sakamoto, Hikaru ^a   Ueno, Shuichi ^a   Kusunoki, Susumu ^a   Nakamura, Yusaku ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Deglutition; DOSS; Dysphagia; Parkinson s disease; Rotigotine

Indexed keywords

ROTIGOTINE; DOPAMINE RECEPTOR STIMULATING AGENT; TETRALIN DERIVATIVE; THIOPHENE DERIVATIVE;

AGED; ARTICLE; ASPIRATION PNEUMONIA; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DYSPHAGIA; FEMALE; FLUOROSCOPY; HUMAN; HYPERSALIVATION; MALE; NON INVASIVE PROCEDURE; OPEN STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSDERMAL PATCH; UNIFIED HUNTINGTON DISEASE RATING SCALE; VERY ELDERLY; VIDEOFLUOROSCOPY; COMPLICATION; CUTANEOUS DRUG ADMINISTRATION; DEGLUTITION DISORDERS; DRUG EFFECTS; PATHOPHYSIOLOGY; SWALLOWING;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; DEGLUTITION; DEGLUTITION DISORDERS; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; PARKINSON DISEASE; RETROSPECTIVE STUDIES; TETRAHYDRONAPHTHALENES; THIOPHENES;

EID: 84937849614     PISSN: 0179051X     EISSN: 14320460     Source Type: Journal    
DOI: 10.1007/s00455-015-9622-5     Document Type: Article

References (20)

1. Muller J, Wenning GK, Verny M, McKee A, Chaudhuri KR, Jellinger K, Poewe W, Litvan I. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol. 2001;58:259–64.
2. Isono C, Hirano M, Sakamoto H, Ueno S, Kusunoki S, Nakamura Y. Differences in dysphagia between spinocerebellar ataxia type 3 and type 6. Dysphagia. 2013;28:413–8.
3. Higo R, Nito T, Tayama N. Swallowing function in patients with multiple-system atrophy with a clinical predominance of cerebellar symptoms (MSA-C). Eur Arch Otorhinolaryngol. 2005;262:646–50.
4. Troche MS, Brandimore AE, Okun MS, Davenport PW, Hegland KW. Decreased cough sensitivity and aspiration in Parkinson disease. Chest. 2014;146:1294–9.
5. Melo A, Monteiro L. Swallowing improvement after levodopa treatment in idiopathic Parkinson’s disease: lack of evidence. Parkinsonism Relat Disord. 2013;19:279–81.
6. Tison F, Wiart L, Guatterie M, Fouillet N, Lozano V, Henry P, Barat M. Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson’s disease. Mov Disord. 1996;11:729–32.
7. Jankovic J, Watts RL, Martin W, Boroojerdi B. Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease. Arch Neurol. 2007;64:676–82.
8. LeWitt PA, Lyons KE, Pahwa R. Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study. Neurology. 2007;68:1262–7.
9. Longemann JA. Evaluation and treatment of swallowing disorders. San Diego: College-Hill Press; 1983.
10. O’Neil KH, Purdy M, Falk J, Gallo L. The dysphagia outcome and severity scale. Dysphagia. 1999;14:139–45.
11. Hunter PC, Crameri J, Austin S, Woodward MC, Hughes AJ. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J Neurol Neurosurg Psychiatry. 1997;63:579–83.
12. Warnecke T, Hamacher C, Oelenberg S, Dziewas R. Off and on state assessment of swallowing function in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20:1033–4.
13. Poewe W, Luessi F. Clinical studies with transdermal rotigotine in early Parkinson’s disease. Neurology. 2005;65:S11–4.
14. Watts RL, Jankovic J, Waters C, Rajput A, Boroojerdi B, Rao J. Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease. Neurology. 2007;68:272–6.
15. Gean CJ, Tur E, Maibach HI, Guy RH. Cutaneous responses to topical methyl nicotinate in black, oriental, and caucasian subjects. Arch Dermatol Res. 1989;281:95–8.
16. Giladi N, Boroojerdi B, Korczyn AD, Burn DJ, Clarke CE, Schapira AH. Rotigotine transdermal patch in early Parkinson’s disease: a randomized, double-blind, controlled study versus placebo and ropinirole. Mov Disord. 2007;22:2398–404.
17. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 1994;79:729–42.
18. Jia YX, Sekizawa K, Ohrui T, Nakayama K, Sasaki H. Dopamine D1 receptor antagonist inhibits swallowing reflex in guinea pigs. Am J Physiol. 1998;274:R76–80.
19. Mu L, Sobotka S, Chen J, Su H, Sanders I, Nyirenda T, Adler CH, Shill HA, Caviness JN, Samanta JE, Sue LI, Beach TG. Parkinson disease affects peripheral sensory nerves in the pharynx. J Neuropathol Exp Neurol. 2013;72:614–23.
20. Mu L, Sobotka S, Chen J, Su H, Sanders I, Adler CH, Shill HA, Caviness JN, Samanta JE, Beach TG. Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol. 2013;72:119–29.